plain

DRUG3 trials

Sponsors

Viiv Healthcare UK Limited, Harmony Biosciences LLC, Uniformed Services University of the Health Sciences

Conditions

Dietary IntakeHIV InfectionsPrader-Willi syndrome

Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Trial to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of Orally Administered Capsid Inhibitors in HIV-1 Infected Treatment-Naïve Adults

CompletedCTIS2023-505350-18-00

Viiv Healthcare UK LimitedHIV Infections

Start: 2023-12-15End: 2024-02-07Target: 17Updated: 2024-06-20

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients with Prader-Willi Syndrome

RecruitingCTIS2023-508307-21-00

Harmony Biosciences LLCPrader-Willi syndrome

Start: 2025-03-19Target: 115Updated: 2025-07-25

Unknown Phase

Evaluating Effectiveness of Spices and Herbs to Increase Vegetable Intake Among Military

CompletedNCT05499858

Uniformed Services University of the Health SciencesDietary Intake

Start: 2022-11-06End: 2024-12-31Updated: 2025-08-22